Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2025-12-24 @ 6:44 PM
NCT ID:
NCT03325257
Eligibility Criteria:
Inclusion Criteria:
* Patients with unresectable or metastatic melanoma cared in participating sites,
* Patients included in French nivolumab ATU program,
* Patients treated by at least one perfusion of nivolumab,
* Patients agreed to participate to the study.
Exclusion Criteria:
* Patients with unresectable or metastatic melanoma not included in French nivolumab ATU program,
* Patients having initiated Nivolumab after the 31th December 2015,
* Patients disagreed to participate.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03325257
Study Brief:
Protocol Section:
NCT03325257